GSK plc
GSKFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
39,848
Cost of Revenue
11,491
Gross Profit
28,357
Gross Margin
71.2%
Operating Income
5,107
Operating Margin
12.8%
Net Income
3,270
Net Margin
8.2%
EPS (Basic)
$1.26
EPS (Diluted)
$1.24
EBITDA
8,468
EBITDA Margin
21.3%
2023
12/31/2023
Revenue
38,517
Cost of Revenue
10,878
Gross Profit
27,639
Gross Margin
71.8%
Operating Income
8,566
Operating Margin
22.2%
Net Income
6,259
Net Margin
16.2%
EPS (Basic)
$2.44
EPS (Diluted)
$2.40
EBITDA
11,535
EBITDA Margin
29.9%
2022
12/31/2022
Revenue
37,241
Cost of Revenue
12,134
Gross Profit
25,108
Gross Margin
67.4%
Operating Income
8,170
Operating Margin
21.9%
Net Income
18,994
Net Margin
51.0%
EPS (Basic)
$2.44
EPS (Diluted)
$2.40
EBITDA
10,923
EBITDA Margin
29.3%
2021
12/31/2021
Revenue
31,364
Cost of Revenue
10,367
Gross Profit
20,997
Gross Margin
66.9%
Operating Income
5,533
Operating Margin
17.6%
Net Income
5,569
Net Margin
17.8%
EPS (Basic)
$2.74
EPS (Diluted)
$2.70
EBITDA
8,236
EBITDA Margin
26.3%
2020
12/31/2020
Revenue
30,930
Cost of Revenue
10,070
Gross Profit
20,860
Gross Margin
67.4%
Operating Income
7,593
Operating Margin
24.6%
Net Income
7,301
Net Margin
23.6%
EPS (Basic)
$2.88
EPS (Diluted)
$2.86
EBITDA
10,245
EBITDA Margin
33.1%